How to take epitalon peptide: dosing, timing, and cycles

Last updated 2026-07-26

What is the standard epitalon dosing protocol?

The protocol that shows up most often in the peptide community and in the Russian source literature is 5-10mg per day, injected subcutaneously, for 10 to 20 consecutive days, then stopped for months. Some versions run 5mg/day for 10 days as a minimal course, others push to 10mg/day for 20 days for what users call a "full course." There is no dose-ranging human trial that establishes which of these is correct, or whether either beats the other. The original Russian work on epitalon (often spelled epithalon in that literature) came out of the group led by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Their published human studies, including work on elderly patients with retinal and pineal gland dysfunction, used injectable courses in this same rough range, generally 5-10mg daily for one to three weeks. Later animal work from the same group and collaborators tested epitalon in mice and rats at various doses to look at tumor incidence, lifespan, and melatonin rhythm, but rodent dosing doesn't translate directly to a human milligram figure by simple weight scaling, and nobody has published a controlled pharmacokinetic study in humans that would let you do that math with confidence ^[1]. So when someone tells you "the protocol" is 10mg/day for 10 days, understand that's a convention borrowed from decades-old Russian clinical papers and refined by word of mouth in longevity forums, not a dose established by modern randomized trials. If you want a starting point anyway, 5-10mg/day subcutaneous for 10-20 days is the range you'll see repeated most consistently across sources ^[2]. For help translating a given vial concentration into an actual daily draw, an epitalon dosage calculator can save you the arithmetic errors that are common with peptides reconstituted at home.

How do you inject epitalon (subcutaneous technique)?

Epitalon is injected subcutaneously, meaning under the skin rather than into muscle. The typical injection sites are the same ones used for insulin: the abdomen around the navel, the front of the thigh, or the back of the upper arm, rotated day to day to avoid irritation at any one spot. After reconstituting the lyophilized (freeze-dried) powder with bacteriological or sterile water, users draw the calculated dose into an insulin syringe (typically 29-31 gauge), pinch a fold of skin, and inject at roughly a 45 to 90 degree angle depending on the amount of subcutaneous fat at the site. The injection itself takes seconds. Most people report minimal pain, comparable to a glucose test strip prick, though site redness or a small welt is common and usually resolves within a day. There's no published clinical protocol specifying an exact needle gauge or injection angle for epitalon specifically, so the technique borrowed here comes from general subcutaneous injection practice used for insulin and other peptide therapies, not from epitalon-specific trials. If you're new to self-injection, a walkthrough on Epitalon how to inject covers reconstitution ratios and sterile handling in more depth than fits here.

What time of day should you take epitalon?

There isn't strong evidence dictating a specific time of day for epitalon injections, and the source studies don't report controlling for time of administration as a variable. Most users inject in the morning or before bed, largely for convenience and because some anecdotal reports associate epitalon with melatonin-related effects, given that some of the animal research looked at pineal gland function and circadian markers ^[1]. The biological rationale some cite is that epitalon has been studied for its effect on the pineal gland's melatonin production in aging animals and in a subset of elderly human subjects, with the Khavinson group reporting normalized melatonin rhythms after epitalon courses in some of their aging cohorts. But this is a different claim from timing your own injection around your own melatonin cycle, and there's no trial testing whether morning versus evening dosing changes outcomes in humans. Pick a time you'll actually stick to for the full course. Consistency across the 10-20 day run probably matters more than the specific hour.

How long should an epitalon cycle last, and how often do you repeat it?

Typical cycles run 10 to 20 consecutive days of daily injections, followed by a rest period commonly described as two to six months before repeating. Some protocols suggest doing this once or twice per year; others describe quarterly courses. None of these repeat schedules come from a controlled trial testing cycle frequency against outcomes in humans. The rationale in the Russian literature for a short course followed by a long break relates to the peptide's proposed action, essentially resetting or supporting a regulatory signal rather than needing continuous occupancy the way a daily supplement or hormone replacement might. Khavinson's group described courses of 10-20 days as sufficient to produce measured effects on melatonin and other markers in their aging patient cohorts, with effects reportedly persisting for months afterward, which is the basis for the long rest periods people use. But "reportedly persisting" here refers to their own uncontrolled observational reporting, not a placebo-controlled trial with defined endpoints. If you're planning how a protocol fits into a year, a dedicated breakdown of Epitalon cycle length walks through the different course-length variants people use and why the rest-period logic exists. Worth reading before you commit to a schedule, since the "right" cycle length really is unsettled.

Does epitalon actually lengthen telomeres or increase telomerase activity in humans?

No human trial has demonstrated that epitalon lengthens telomeres or measurably increases telomerase activity in living people. The telomerase claim traces back almost entirely to a single line of research: cell culture and rodent studies from Khavinson's group and collaborators, which reported that epitalon increased telomerase activity in human somatic cell cultures and extended lifespan in some rodent and fish studies ^{[1] [3]}. One of the most-cited papers, published in Neuroendocrinology Letters, reported that epithalon activated telomerase and increased proliferative potential in human fibroblast cell lines in vitro ^[3]. That's a real, published finding, and it's the actual foundation of the "epitalon activates telomerase" claim you'll see everywhere online. But it's a cell culture result. It tells you something happened to isolated cells in a dish, not what happens to telomeres in a living human body, where the peptide has to survive circulation, reach relevant tissue, and act on a target across a whole organism with feedback systems a dish doesn't have. The rodent lifespan data adds a second layer, separate from the telomerase claim. Some studies from the same research group reported increased median lifespan and reduced spontaneous tumor incidence in mice given epitalon compared to untreated controls ^[1]. Again, real published data, but mouse studies, run by a research group whose work on this compound has not been independently replicated by labs outside that network, at least not in the peer-reviewed literature indexed on PubMed as of this writing. No independent lab outside the original Russian research group has published a replication showing epitalon extends telomeres or lifespan in mammals at a scale that would satisfy a skeptical reviewer, and there is no human telomere-length trial at all. That gap between "activates telomerase in a dish" and "lengthens telomeres in your body" is the single most important thing to understand before you decide epitalon does what the marketing implies. For a fuller breakdown of the primary studies and their limitations, see epitalon peptide before and after.

What results can you realistically expect, and on what timeline?

Based on the existing published research, the honest answer is: nobody has good data on what epitalon does for a healthy adult taking it recreationally, on any timeline. The human studies that exist come from an aging or clinically compromised population studied by one research group, using endpoints like melatonin rhythm normalization and general markers in elderly subjects, not the anti-aging or cognitive benefits often advertised in the peptide retail space ^[2]. Users self-reporting online describe subjective improvements in sleep quality within the first course, sometimes mood or skin appearance changes over subsequent cycles, but these are anecdotal reports without controls, blinding, or objective measurement, and they're exactly the kind of reports that placebo effects and selection bias produce reliably regardless of what's in the syringe. If you're looking for a number, here's what the literature actually supports: in Khavinson's reported human studies, courses of about 10-20 days were associated with normalized melatonin excretion patterns measured over subsequent months in elderly subjects, and in the group's animal studies, treated rodent cohorts showed increased median lifespan and lower tumor rates compared to controls ^[1]. Nothing in the published literature supports claims about human lifespan extension, reversal of visible aging signs, or telomere lengthening in people. Any retailer or forum post stating those as settled facts is going beyond what the data shows.

Is epitalon legal to buy and use, and is it FDA approved?

Epitalon is not FDA approved for any use in the United States. It's sold by research chemical and peptide vendors labeled "for research purposes only," which is the standard workaround vendors use to sell substances that haven't gone through FDA review for human use. The FDA has broad statutory authority to regulate drugs marketed for human use, and it treats unapproved peptides sold for human consumption, including epitalon, as outside any legitimate regulatory pathway when marketed that way. Under 21 U.S.C. 355(a), no new drug may be introduced into interstate commerce without an approved application, and epitalon has no such approval on file ^[4]. That doesn't make personal possession illegal in most cases, but it does mean there's no FDA-verified manufacturing, purity, or dosing standard behind any given vial you buy, and quality varies a lot by supplier. This is the actual practical safety issue for most users: not epitalon's biological effects, which are understudied, but sourcing quality. Third-party testing (certificate of analysis for purity and identity) is the minimum bar for a legitimate supplier, and even that only confirms what's in the vial, not that it's safe or effective for your purpose.

What are the side effects and safety risks of epitalon?

The published human data on epitalon's safety comes almost entirely from the same small set of Russian studies, generally describing it as well tolerated in the elderly cohorts studied, with no serious adverse events specifically attributed to it in those reports ^[2]. That is a thin safety record. It's not the kind of adverse-event database the FDA would require for approval, and it doesn't cover younger healthy adults, pregnant people, people on other medications, or long-term repeated use over years. Common minor issues reported anecdotally by current users include injection site redness or itching, mild headache in the first days of a course, and occasional fatigue. These are consistent with generic injection-related effects rather than anything specific documented in controlled epitalon research. The bigger unknown is drug interactions and contraindications, because no formal interaction studies exist. If you're on other medications, have a diagnosed illness, are pregnant or breastfeeding, or have a personal or family cancer history, that's a conversation for a doctor before you start, not something to guess about based on a forum thread. Given the sourcing issues above, working through a provider-reviewed pathway rather than an anonymous research-chemical vendor at least adds a layer of oversight to the parts of this you actually can control, dose accuracy and product quality, even where the underlying human efficacy data stays thin.

Epitalon vs epithalon: is there a difference?

No. Epitalon and epithalon are the same synthetic tetrapeptide (Ala-Glu-Asp-Gly), and the spelling difference is just a transliteration artifact from Russian to English. "Epithalon" leans closer to the original Russian transliteration used in Khavinson's papers; "epitalon" is the more common spelling in Western retail and forum use. Some sellers even mix both spellings on the same product page. If you're searching for research, it's worth checking both spellings, because indexing on PubMed and other databases isn't always consistent, and you can miss a relevant paper by only searching one variant ^[3]. There is no different compound, different dose, or different mechanism implied by the spelling. It's purely orthographic.

How should you reconstitute and store epitalon between doses?

Epitalon typically ships as a lyophilized (freeze-dried) powder in a vial, which needs to be reconstituted with bacteriostatic water or sterile water before injection. A common approach is adding 1-3mL of water per 10mg vial, which gives you a concentration you can then dose out in small volumes using an insulin syringe. Once reconstituted, peptides in general degrade faster than in powder form, and most peptide handling guidance (drawn from general peptide stability practice rather than epitalon-specific studies) recommends refrigeration at 2-8°C for reconstituted product, used within roughly 2-4 weeks, with the unreconstituted powder stable for much longer if kept cold and out of light. There's no published epitalon-specific stability study establishing an exact shelf life after reconstitution, so these windows are extrapolated from general peptide handling standards, not from data on this molecule specifically. Avoid repeated freeze-thaw cycles and don't leave a reconstituted vial at room temperature for extended periods. If precise concentration math for your specific vial size is tripping you up, that's exactly what the epitalon dosage calculator is built for.

How long does epitalon stay active in the body?

Epitalon's half-life in humans hasn't been formally established through published pharmacokinetic studies, which is a real gap given how often specific half-life numbers get quoted online. As a small linear tetrapeptide, it's reasonable to expect rapid degradation by peptidases in circulation, likely on the order of minutes, similar to other unmodified short peptides, but that's an inference from peptide chemistry generally, not a measured number specific to epitalon from a clinical pharmacokinetic trial. This short expected half-life is part of the logic behind daily dosing during a course. If the peptide clears quickly, a single injection wouldn't sustain any proposed signaling effect, hence the daily repeat over 10-20 days rather than a single dose or occasional dosing. For the fuller mechanistic discussion and what's actually measurable versus inferred, see Epitalon half life.

Should you take epitalon orally, or does it have to be injected?

Injectable subcutaneous administration is what's used in essentially all of the published research and in the community protocols that follow it. Oral epitalon products exist on the retail market, but there's no published data showing the peptide survives oral administration and gastrointestinal digestion intact in a way that produces the same effects seen with injection. As a small peptide, epitalon is a reasonable candidate for breakdown by digestive enzymes before it would reach systemic circulation in meaningful amounts, which is the general problem with oral peptide products across the category, not something specific to epitalon. If a vendor is selling oral capsules or sublingual drops and citing the Khavinson injectable studies as their evidence, that's a mismatch between the delivery route studied and the product sold. Worth noticing before you pay a premium for a format with no supporting data of its own.

Frequently asked questions

What is the typical epitalon dosage for a first course?

Most first-time protocols use 5-10mg per day by subcutaneous injection for 10 days. This comes from patterns in the Russian clinical literature and community use, not a dose-ranging human trial, so treat it as a conservative starting convention rather than a scientifically optimized figure.

How many days in a row do you inject epitalon?

Courses typically run 10 to 20 consecutive days of daily injections, followed by a rest period of two to six months before another course. Longer 20-day courses are sometimes used at the lower end of the dose range (5mg/day); shorter 10-day courses sometimes pair with higher daily doses (10mg/day).

Can epitalon be taken orally instead of injected?

Oral products exist commercially, but no published research supports oral epitalon producing the effects seen with injection. As a small peptide, it's likely broken down by digestive enzymes before absorption. All the human and animal data behind epitalon's claims used injectable, not oral, administration.

Does epitalon really increase telomerase activity?

In human cell cultures, yes, one study published in Neuroendocrinology Letters reported epithalon activated telomerase in fibroblast cell lines. That's a lab dish finding. No human trial has shown epitalon increases telomerase activity or lengthens telomeres in a living person.

Is epitalon the same as epithalon?

Yes, they're the same tetrapeptide (Ala-Glu-Asp-Gly). "Epithalon" is closer to the original Russian transliteration used in the source studies; "epitalon" is the more common spelling in Western retail contexts. Search both spellings if you're looking for research.

What time of day is best to inject epitalon?

There's no clinical evidence establishing an optimal injection time. Most users choose morning or bedtime for convenience. Some cite epitalon's studied link to pineal gland and melatonin function as a reason to dose at night, but no trial has tested timing as a variable.

Is epitalon FDA approved or legal to buy?

Epitalon is not FDA approved for any human use in the United States. Under 21 U.S.C. 355(a), no unapproved new drug may be sold in interstate commerce for human use, and epitalon has no approved application on file. It's sold as a research chemical, and no FDA-verified purity or dosing standard exists for retail vials.

How long should you wait between epitalon cycles?

Common practice uses a rest period of two to six months between 10-20 day courses, with cycles repeated once or twice a year. This spacing comes from Russian clinical protocols and community convention, not from a controlled trial testing different rest intervals against outcomes.

What are the known side effects of epitalon?

Published Russian studies in elderly subjects report it as generally well tolerated, with no serious adverse events specifically attributed to it. Anecdotally, users report mild injection site redness, occasional headache, or fatigue in the first days. Long-term and younger-population safety data doesn't exist in the peer-reviewed literature.

Has epitalon been shown to extend human lifespan?

No. Lifespan extension has been reported in rodent and some invertebrate/fish studies from the Khavinson research group, not in humans. No human trial has measured or demonstrated a lifespan extension effect from epitalon. This claim, as commonly stated online, outpaces the actual evidence.

How do you calculate the right epitalon dose from a vial?

You need the vial's total peptide amount (commonly 10mg), the reconstitution volume of water added, and your target daily dose in mg to work out the injection volume in an insulin syringe. Getting this math wrong is a common source of dosing errors; a dedicated calculator tool removes the guesswork.

Can you take epitalon long-term without cycling off?

No published research tests continuous, uncycled epitalon use in humans. Every established protocol in the source literature and community practice uses short courses (10-20 days) followed by extended breaks. There's no safety or efficacy data supporting continuous daily use over months or years.

Sources

1. Anisimov VN, Khavinson VK, "Peptide bioregulation of aging: results and prospects", Biogerontology 2010: Epitalon has been reported to increase median lifespan and reduce spontaneous tumor incidence in treated rodent cohorts versus controls
2. Khavinson VK, Morozov VG, "Peptides of pineal gland and thymus prolong human life", Neuroendocrinology Letters 2003: The published epitalon literature is dominated by a small number of Russian research groups using consistent short-course injectable dosing ranges
3. Khavinson VK, Bondarev IE, Butyugov AA, "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells", Bulletin of Experimental Biology and Medicine 2003: Epithalon was reported to activate telomerase and increase proliferative potential in human fibroblast cell cultures
4. 21 U.S.C. 355 - New drugs (Federal Food, Drug, and Cosmetic Act Section 505): No unapproved new drug may be introduced into interstate commerce for human use without an approved application
5. Anisimov VN et al., "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived mice", Mechanisms of Ageing and Development 2003: Treated rodent cohorts showed increased median lifespan and lower spontaneous tumor rates compared to controls in Epitalon studies